Cargando…
Hormonal control of p53 and chemoprevention
Improvements in the detection and treatment of breast cancer have dramatically altered its clinical course and outcome. However, prevention of breast cancer remains an elusive goal. Parity, age of menarche, and age at menopause are major risk factors drawing attention to the important role of the en...
Autores principales: | Jerry, D Joseph, Minter, Lisa M, Becker, Klaus A, Blackburn, Anneke C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138728/ https://www.ncbi.nlm.nih.gov/pubmed/12052250 http://dx.doi.org/10.1186/bcr431 |
Ejemplares similares
-
Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
por: Blackburn, Anneke C, et al.
Publicado: (2002) -
Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice
por: Blackburn, Anneke C, et al.
Publicado: (2014) -
Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53(+/- )mice
por: Dunphy, Karen A, et al.
Publicado: (2008) -
Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
por: Blackburn, AC, et al.
Publicado: (2012) -
Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)